Rahul Banerjee, Assistant Professor at the Fred Hutchinson Cancer Center and at the University of Washington, shared a post on X:
“From paternity leave to plasma cells (for ≤ 2 hours until I have to go back to duty)…
Excited to be here at Binaytara, Seattle CT 2025 cell therapy summit!
Thanks, Mazyar Shadman, Krish Patel, and Binay Shah, for organizing and inviting me!
And my final slide for Seattle CT 2025, Binaytara, talks about approved CAR-T therapies in MM.
Including an excellent paraphrased pearl of wisdom from Rafael Fonseca: CAR-T at 1st relapse in US is only debated because it’s new…
But maybe it should be our default frame of reference!”
More posts featuring Rahul Banerjee.
